481 related articles for article (PubMed ID: 26567244)
1. B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome.
Colucci M; Carsetti R; Cascioli S; Casiraghi F; Perna A; Ravà L; Ruggiero B; Emma F; Vivarelli M
J Am Soc Nephrol; 2016 Jun; 27(6):1811-22. PubMed ID: 26567244
[TBL] [Abstract][Full Text] [Related]
2. CyTOF-Enabled Analysis Identifies Class-Switched B Cells as the Main Lymphocyte Subset Associated With Disease Relapse in Children With Idiopathic Nephrotic Syndrome.
Fribourg M; Cioni M; Ghiggeri G; Cantarelli C; Leventhal JS; Budge K; Bin S; Riella LV; Colucci M; Vivarelli M; Angeletti A; Perin L; Cravedi P
Front Immunol; 2021; 12():726428. PubMed ID: 34621271
[TBL] [Abstract][Full Text] [Related]
3. Relapse of nephrotic syndrome during post-rituximab peripheral blood B-lymphocyte depletion.
Sato M; Kamei K; Ogura M; Ishikura K; Ito S
Clin Exp Nephrol; 2018 Feb; 22(1):110-116. PubMed ID: 28434126
[TBL] [Abstract][Full Text] [Related]
4. Prolonged Impairment of Immunological Memory After Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic Syndrome.
Colucci M; Carsetti R; Serafinelli J; Rocca S; Massella L; Gargiulo A; Lo Russo A; Capponi C; Cotugno N; Porzio O; Onetti Muda A; Palma P; Emma F; Vivarelli M
Front Immunol; 2019; 10():1653. PubMed ID: 31379849
[TBL] [Abstract][Full Text] [Related]
5. Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome.
Maxted AP; Dalrymple RA; Chisholm D; McColl J; Tse Y; Christian MT; Reynolds BC
Pediatr Nephrol; 2019 May; 34(5):855-863. PubMed ID: 30564878
[TBL] [Abstract][Full Text] [Related]
6. B cell phenotype in pediatric idiopathic nephrotic syndrome.
Colucci M; Carsetti R; Cascioli S; Serafinelli J; Emma F; Vivarelli M
Pediatr Nephrol; 2019 Jan; 34(1):177-181. PubMed ID: 30267238
[TBL] [Abstract][Full Text] [Related]
7. Effect of different rituximab regimens on B cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome.
Hogan J; Dossier C; Kwon T; Macher MA; Maisin A; Couderc A; Niel O; Baudouin V; Deschênes G
Pediatr Nephrol; 2019 Feb; 34(2):253-259. PubMed ID: 30109447
[TBL] [Abstract][Full Text] [Related]
8. Rituximab efficiency in children with steroid-dependent nephrotic syndrome.
Sellier-Leclerc AL; Macher MA; Loirat C; Guérin V; Watier H; Peuchmaur M; Baudouin V; Deschênes G
Pediatr Nephrol; 2010 Jun; 25(6):1109-15. PubMed ID: 20238230
[TBL] [Abstract][Full Text] [Related]
9. Human or Chimeric Monoclonal Anti-CD20 Antibodies for Children with Nephrotic Syndrome: A Superiority Randomized Trial.
Ravani P; Colucci M; Bruschi M; Vivarelli M; Cioni M; DiDonato A; Cravedi P; Lugani F; Antonini F; Prunotto M; Emma F; Angeletti A; Ghiggeri GM
J Am Soc Nephrol; 2021 Oct; 32(10):2652-2663. PubMed ID: 34544820
[TBL] [Abstract][Full Text] [Related]
10. Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing/steroid-dependent nephrotic syndrome.
Colucci M; Angeletti A; Zotta F; Carsetti R; Lugani F; Ravà L; Ravani P; Emma F; Ghiggeri GM; Vivarelli M
Kidney Int; 2023 Sep; 104(3):577-586. PubMed ID: 37385541
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab.
Kamei K; Ishikura K; Sako M; Aya K; Tanaka R; Nozu K; Kaito H; Nakanishi K; Ohtomo Y; Miura K; Takahashi S; Morimoto T; Kubota W; Ito S; Nakamura H; Iijima K;
Pediatr Nephrol; 2017 Nov; 32(11):2071-2078. PubMed ID: 28664242
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic nephrotic syndrome and rituximab: may we predict circulating B lymphocytes recovery?
Delbet JD; Leclerc G; Ulinski T
Pediatr Nephrol; 2019 Mar; 34(3):529-532. PubMed ID: 30542932
[TBL] [Abstract][Full Text] [Related]
13. Atypical IgM on T cells predict relapse and steroid dependence in idiopathic nephrotic syndrome.
Colucci M; Carsetti R; Rosado MM; Cascioli S; Bruschi M; Candiano G; Corpetti G; Giardino L; Serafinelli J; Giannone C; Ghiggeri GM; Rastaldi MP; Sitia R; Emma F; Vivarelli M
Kidney Int; 2019 Oct; 96(4):971-982. PubMed ID: 31285081
[TBL] [Abstract][Full Text] [Related]
14. Rituximab modulates T- and B-lymphocyte subsets and urinary CD80 excretion in patients with steroid-dependent nephrotic syndrome.
Bhatia D; Sinha A; Hari P; Sopory S; Saini S; Puraswani M; Saini H; Mitra DK; Bagga A
Pediatr Res; 2018 Oct; 84(4):520-526. PubMed ID: 29983411
[TBL] [Abstract][Full Text] [Related]
15. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K; Sako M; Nozu K; Mori R; Tuchida N; Kamei K; Miura K; Aya K; Nakanishi K; Ohtomo Y; Takahashi S; Tanaka R; Kaito H; Nakamura H; Ishikura K; Ito S; Ohashi Y;
Lancet; 2014 Oct; 384(9950):1273-81. PubMed ID: 24965823
[TBL] [Abstract][Full Text] [Related]
16. Rituximab in steroid-dependent nephrotic syndrome.
El Koumi M
Iran J Kidney Dis; 2013 Nov; 7(6):502-6. PubMed ID: 24241100
[TBL] [Abstract][Full Text] [Related]
17. Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials.
Iijima K; Sako M; Kamei K; Nozu K
Pediatr Nephrol; 2018 Sep; 33(9):1449-1455. PubMed ID: 28717938
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of patients with early relapse during B-cell depletion after rituximab treatment for complicated steroid-dependent nephrotic syndrome.
Fujinaga S; Endo S; Onuki Y
Clin Exp Nephrol; 2021 Apr; 25(4):441-442. PubMed ID: 33409760
[No Abstract] [Full Text] [Related]
19. Rituximab treatment in pediatric patients with steroid-dependent nephrotic syndrome: A tertiary hospital.
Guzmán Morais B; Ordóñez Álvarez FÁ; Santos Rodríguez F; Martín Ramos S; Fernández Novo G
An Pediatr (Engl Ed); 2022 Feb; 96(2):83-90. PubMed ID: 35144901
[TBL] [Abstract][Full Text] [Related]
20. The effect of systemic corticosteroids on the innate and adaptive immune system in children with steroid responsive nephrotic syndrome.
Baris HE; Baris S; Karakoc-Aydiner E; Gokce I; Yildiz N; Cicekkoku D; Ogulur I; Ozen A; Alpay H; Barlan I
Eur J Pediatr; 2016 May; 175(5):685-93. PubMed ID: 26833050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
